Your session is about to expire
← Back to Search
Intrathecal Hydromorphone for Pain Management in Scoliosis Repair
Study Summary
This trial is testing different doses of an opioid pain medication to find the best balance of pain relief and side effects.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have conditions that make spinal anesthesia risky for me.I am having back surgery for scoliosis through an approach from the back.I do not have chronic pain, haven't used opioids before surgery, and my pain score is below 3.
- Group 1: Intrathecal Hydromorphone 4.5 mcg/kg
- Group 2: Intrathecal Hydromorphone 2.5 mcg/kg
- Group 3: Intrathecal Hydromorphone 2.75 mcg/kg
- Group 4: Intrathecal Hydromorphone 3 mcg/kg
- Group 5: Intrathecal Hydromorphone 3.25 mcg/kg
- Group 6: Intrathecal Hydromorphone 3.5 mcg/kg
- Group 7: Intrathecal Hydromorphone 4 mcg/kg
- Group 8: Intrathecal Hydromorphone 5 mcg/kg
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are geriatric individuals eligible to enroll in this research endeavor?
"This trial has an age-range restriction of 10 to 17 years old that all participants must meet in order to be eligible."
Has the federal regulatory body sanctioned Intrathecal Hydromorphone 3.5 mcg/kg for usage?
"After review, the safety of Intrathecal Hydromorphone 3.5 mcg/kg was rated a 3, as this is an approved Phase 4 trial."
What types of individuals are suitable for this clinical trial?
"The parameters for this clinical trial include pain and an age range between 10 and 17; 40 applicants are needed to reach the maximum capacity of the study."
Are there any positions available to volunteer for this clinical trial?
"Presently, the information published on clinicaltrials.gov reveals that this study is not looking for any new participants. This trial was initially advertised on November 1st 2022 and subsequently updated nine months later (September 2020). Although there are no current openings in this research project, 78 other studies have open enrollment at present."
Share this study with friends
Copy Link
Messenger